Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease
- PMID: 34035752
- PMCID: PMC8132655
Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease
Abstract
Hospitalization for inflammatory bowel disease is common and requires coordination of care. The goals of hospitalization are to markedly improve symptoms, transition management to an outpatient regimen, and prevent complications. Initially, providers should determine the phenotype and severity of disease flare and provide optimal medical salvage therapy for induction of disease remission. In addition, complications of Crohn's disease and ulcerative colitis should be addressed with testing for Clostridioides difficile and cytomegalovirus infections and pharmacologic venous thromboembolism prophylaxis, and early enteral feeding should be encouraged to optimize nutritional status. A standardized daily assessment to determine response to treatment should be performed. Objective measures of response to disease treatment that are measured within 3 to 4 days of hospitalization can predict which patients will benefit from either second-line rescue therapy or surgical intervention. These same measures can be used to determine readiness for hospital discharge. Safe discharge can be optimized with thorough patient education and a comprehensive outpatient follow-up plan.
Keywords: Crohn’s disease; Ulcerative colitis; checklist; hospitalization; inflammatory bowel disease.
Copyright © 2020, Gastro-Hep Communications, Inc.
Conflict of interest statement
The authors have no relevant conflicts of interest to disclose.
Similar articles
-
Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol.Inflamm Bowel Dis. 2019 Oct 18;25(11):1822-1827. doi: 10.1093/ibd/izz066. Inflamm Bowel Dis. 2019. PMID: 30980712
-
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.Am J Gastroenterol. 2000 Mar;95(3):677-83. doi: 10.1111/j.1572-0241.2000.01845.x. Am J Gastroenterol. 2000. PMID: 10710056
-
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5. Acta Dermatovenerol Croat. 2016. PMID: 27149138
-
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.
-
Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.Dis Mon. 1991 Nov;37(11):669-746. doi: 10.1016/s0011-5029(05)80013-6. Dis Mon. 1991. PMID: 1935537 Review.
Cited by
-
Role of hospitalization for inflammatory bowel disease in the post-biologic era.World J Clin Cases. 2021 Sep 16;9(26):7632-7642. doi: 10.12998/wjcc.v9.i26.7632. World J Clin Cases. 2021. PMID: 34621815 Free PMC article. Review.
-
Impact of Biologics and Proton Pump Inhibitors on Gastrointestinal Infection Risk in Inflammatory Bowel Disease Patients: A Retrospective Analysis of Pathogen-Specific Outcomes and Treatment Interactions.Biomedicines. 2025 Jul 8;13(7):1676. doi: 10.3390/biomedicines13071676. Biomedicines. 2025. PMID: 40722748 Free PMC article.
-
Inhibition of IEC-6 Cell Proliferation and the Mechanism of Ulcerative Colitis in C57BL/6 Mice by Dandelion Root Polysaccharides.Foods. 2023 Oct 17;12(20):3800. doi: 10.3390/foods12203800. Foods. 2023. PMID: 37893693 Free PMC article.
-
Prevalence of Steroid-Induced Hyperglycemia in King Abdulaziz Specialist Hospital, Taif City, Saudi Arabia.Cureus. 2024 Feb 18;16(2):e54430. doi: 10.7759/cureus.54430. eCollection 2024 Feb. Cureus. 2024. PMID: 38510914 Free PMC article.
-
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report.Case Rep Oncol. 2023 Jun 16;16(1):438-445. doi: 10.1159/000530832. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37384210 Free PMC article.
References
-
- Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol. 2006;101(1):110–118. - PubMed
LinkOut - more resources
Full Text Sources